With the fact that chronic pain afflicts more than 100 million Americans and amid the current opioid crisis, there is great unmet need for innovative alternatives for the treatment of chronic pain.
This session will report on a multicenter, prospective, randomized, double-blind study of this novel SCS system and will also focus on the value of ECAP monitoring to understand the mechanism of action of SCS as well provide neurophysiologic monitoring of spinal cord function.
Advances in using SCS for the management of cancer-related pain with emphasis on recognizing and mitigating possible complications will also be addressed.
Outcomes of Clinical Trials of SCS using ECAPS to Provide Closed-Loop Control
Nagy Mekhail, MD PhD
ECAPS for Neuro-Monitoring
Steven Falowski, MD
Advances in the Use of Spinal Cord Stimulation in the Treatment of Cancer-Related Pain
Lisa Stearns, MD
- Review the shortfalls of the current ‘fixed output' spinal cord stimulation technology.
- Appraise the value of measuring the Evoked Compound Action Potential ‘ECAP’ as indicator/monitor of spinal cord activation.
- Discuss the value and long-term outcomes of spinal cord stimulation for cancer-related pain.
- Neuromodulation Review 1 (301)
- The Promise and Reality of Regenerative Medicine in Pain Management (307)
- Diagnostic and Prognostic Anesthetic Blocks for Facet, Sacroiliac, and Knee Joint Pain: An Evidence-Based Update (202)
- Frontiers in Denervation for Chronic Pain: Sacroiliac Joint Complex, Knee, Shoulder, and Hip (206)
- Lumbar Facet Block and Radiofrequency Ablation International Consensus Guidelines Part 1 (210)